Market Research Report
Global Gene Therapy Market 2022-2026
|Global Gene Therapy Market 2022-2026|
Published: March 31, 2022
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
Technavio has been monitoring the gene therapy market and it is poised to grow by $ 4.02 bn during 2022-2026 progressing at a CAGR of 19.84% during the forecast period. Our report on the gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in special drug designations, benefits associated with gene therapy, and the rising geriatric population.
The gene therapy market analysis includes therapy area segment and geographic landscape.
Technavio's gene therapy market is segmented as below:
By Therapy Area
By Geographical Landscape
This study identifies the growing research in gene therapy for CVDs and orphan diseases as one of the prime reasons driving the gene therapy market growth during the next few years. Also, partnerships and collaborations are changing the market scenario, and rapid growth potential in developing economies will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the gene therapy market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene therapy market vendors that include Abeona Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc., Applied Genetic Technologies Corp., Amgen Inc., Astellas Pharma Inc., Biogen Inc., bluebird bio Inc., Editas Medicine Inc., ElevateBio, F. Hoffmann La Roche Ltd., Generation Bio, Gilead Sciences Inc., Novartis AG, Orchard Therapeutics Plc, Poseida Therapeutics Inc, Sangamo Therapeutics Inc., Sibiono GeneTech Co. Ltd., uniQure NV, and Voyager Therapeutics Inc. Also, the gene therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.